[go: up one dir, main page]

NO305034B1 - FremgangsmÕte for fremstilling av komplekser av langkjedede, umettede fettsyrer og deres derivater med syklodekstrin - Google Patents

FremgangsmÕte for fremstilling av komplekser av langkjedede, umettede fettsyrer og deres derivater med syklodekstrin Download PDF

Info

Publication number
NO305034B1
NO305034B1 NO913083A NO913083A NO305034B1 NO 305034 B1 NO305034 B1 NO 305034B1 NO 913083 A NO913083 A NO 913083A NO 913083 A NO913083 A NO 913083A NO 305034 B1 NO305034 B1 NO 305034B1
Authority
NO
Norway
Prior art keywords
cyclodextrin
approx
room temperature
complexes
oil
Prior art date
Application number
NO913083A
Other languages
English (en)
Norwegian (no)
Other versions
NO913083L (no
NO913083D0 (no
Inventor
Tiberio Bruzzese
Giovanni Mozzi
Original Assignee
Staroil Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Staroil Ltd filed Critical Staroil Ltd
Publication of NO913083D0 publication Critical patent/NO913083D0/no
Publication of NO913083L publication Critical patent/NO913083L/no
Publication of NO305034B1 publication Critical patent/NO305034B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO913083A 1990-08-09 1991-08-08 FremgangsmÕte for fremstilling av komplekser av langkjedede, umettede fettsyrer og deres derivater med syklodekstrin NO305034B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02125790A IT1243192B (it) 1990-08-09 1990-08-09 Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine

Publications (3)

Publication Number Publication Date
NO913083D0 NO913083D0 (no) 1991-08-08
NO913083L NO913083L (no) 1992-02-10
NO305034B1 true NO305034B1 (no) 1999-03-22

Family

ID=11179136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913083A NO305034B1 (no) 1990-08-09 1991-08-08 FremgangsmÕte for fremstilling av komplekser av langkjedede, umettede fettsyrer og deres derivater med syklodekstrin

Country Status (11)

Country Link
US (1) US5189149A (it)
EP (1) EP0470452B1 (it)
JP (1) JPH072662A (it)
KR (1) KR920004555A (it)
AT (1) ATE128988T1 (it)
CA (1) CA2047884A1 (it)
DE (1) DE69113713T2 (it)
ES (1) ES2079526T3 (it)
IT (1) IT1243192B (it)
NO (1) NO305034B1 (it)
PT (1) PT98606B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612658A1 (de) * 1996-03-29 1997-10-02 Wacker Chemie Gmbh Verfahren zur Stabilisierung und Dispergierung von Pflanzenölen, die mehrfach ungesättigte Fettsäurereste enthalten, mittels gamma-Cyclodextrin sowie derart hergestellte Komplexe und ihre Verwendung
FR2790758A1 (fr) * 1999-03-09 2000-09-15 Commissariat Energie Atomique Solubilisation d'acides gras polyinsatures et de leurs derives par formation de complexes d'inclusion avec une cyclodextrine et leur utilisation dans des compositions pharmaceutiques, cosmetiques ou alimentaires
DE69900155T2 (de) * 1999-04-01 2001-10-11 Wacker Biochem Corp., Adrian Verfahren zur Stabilisierung von Acylglycerinen, die einen hohen Anteil an w-3 mehrfach ungesättigten Fettsäuren enthalten, mittels gamma-Cyclodextrin
FR2825714B1 (fr) * 2001-06-08 2005-03-25 Seppic Sa Nouvelle utilisation de complexes d'inclusion de cyclodestrine
US6638557B2 (en) * 2001-08-14 2003-10-28 Cerestar Holding B.V. Dry, edible oil and starch composition
US20030190402A1 (en) * 2002-04-04 2003-10-09 Mcbride Christine Reduced fat foodstuff with improved flavor
CA2480668C (en) 2002-08-19 2009-11-24 Art Jen Complexus, Inc. Compositions comprising dietary fat complexer and methods for their use
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
US20040109920A1 (en) * 2002-12-04 2004-06-10 Bioactives Llc Coated carotenoid cyclodextrin complexes
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US7125833B2 (en) * 2003-03-24 2006-10-24 Wacker Chemie Ag Cyclodextrin laundry detergent additive complexes and compositions containing same
CA2547934C (en) * 2004-02-19 2013-05-21 Abbott Laboratories Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
US7781572B2 (en) * 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
FR2898817B1 (fr) * 2006-03-23 2008-08-08 Univ Rouen Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines
KR100832796B1 (ko) * 2006-08-23 2008-05-27 주식회사 마크로케어 사이클로덱스트린을 이용한 스쿠알렌 또는 스쿠알란의 추출방법 및 그 방법에 의해 제조된 포접체를 함유하는 화장료 조성물
ITMI20061672A1 (it) * 2006-09-01 2008-03-02 Altergon Sa Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
WO2008083213A2 (en) * 2006-12-27 2008-07-10 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
WO2009078030A1 (en) * 2007-12-17 2009-06-25 Alkem Laboratories Limited Fat substitute
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions
GB0817701D0 (en) * 2008-09-26 2008-11-05 Omegatri As Krill oil powder and krill oil tablets
JP5572323B2 (ja) * 2009-03-04 2014-08-13 備前化成株式会社 包摂反応においてホスト化合物の選択性を高める低分子多糖類、およびそれを用いた苦味成分および臭い成分を包摂する方法
DE102010023790A1 (de) 2010-06-15 2011-12-15 Heinrich-Heine-Universität Düsseldorf Waschaktive Zusammensetzung
ITMI20112244A1 (it) * 2011-12-12 2013-06-13 S I I T S R L Complesso di inclusione tra una ciclodestrina e un olio vegetale e suo impiego
CN107666904B (zh) 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
CN109069519A (zh) * 2016-04-27 2018-12-21 物心科技株式会社 含有醚型甘油磷脂的组合物和其制造方法
CA3154975A1 (en) * 2019-10-16 2021-04-22 Daniel A. Pearson Cyclodextrin-based gammalinolenic acid formulation for treatment of brain cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
JPS6034156A (ja) * 1983-08-08 1985-02-21 Hayashibara Biochem Lab Inc エイコサペンタエン酸包接化合物及びこれを含有した飲食物
FR2596617B1 (fr) * 1986-04-08 1990-10-05 Orstom Composition a base d'acide gras complexe par des cyclodextrines, son procede de preparation et application phytosanitaire
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Also Published As

Publication number Publication date
EP0470452A3 (en) 1992-04-29
ES2079526T3 (es) 1996-01-16
IT9021257A0 (it) 1990-08-09
DE69113713D1 (de) 1995-11-16
NO913083L (no) 1992-02-10
ATE128988T1 (de) 1995-10-15
JPH072662A (ja) 1995-01-06
NO913083D0 (no) 1991-08-08
DE69113713T2 (de) 1996-03-21
PT98606A (pt) 1992-06-30
KR920004555A (ko) 1992-03-27
EP0470452B1 (en) 1995-10-11
IT1243192B (it) 1994-05-24
EP0470452A2 (en) 1992-02-12
CA2047884A1 (en) 1992-02-10
US5189149A (en) 1993-02-23
IT9021257A1 (it) 1992-02-09
PT98606B (pt) 1999-01-29

Similar Documents

Publication Publication Date Title
NO305034B1 (no) FremgangsmÕte for fremstilling av komplekser av langkjedede, umettede fettsyrer og deres derivater med syklodekstrin
Saravana et al. Hydrothermal degradation of seaweed polysaccharide: Characterization and biological activities
Hu et al. Purification of lactonic sophorolipids by crystallization
CA2654799A1 (en) Large-particle cyclodextrin inclusion complexes and methods of preparing same
EP0792888A1 (de) Aliphatische Carbonsäureester von Inulin
Wei et al. Efficient synthesis of polysaccharide with high selenium content mediated by imidazole-based acidic ionic liquids
JP2574664B2 (ja) 部分アシル化β−シクロデキストリン、その製造方法およびそれを含有する可溶化剤、調製助剤、安定剤、脱脂剤、代用溶剤ならびに被覆材料、定着助剤、相間移動触媒および味覚および嗅覚マスキング剤
CN1190333A (zh) 含有水溶性β－胡萝卜素的代脂肪
JP3711310B2 (ja) 芳香物質および香気発生物質としての３−アシルチオヘキシルの使用
Hurd et al. Hydroxylation of 2, 3-dihydropyran and the application of desoxyaldopentoses in the browning reaction1
Kajiki et al. Development of novel low-molecular-mass oil-gelling agents: Synthesis and physical properties of 1, 5-anhydro-D-glucitol and 1, 5-anhydro-D-mannitol protected with saturated linear fatty acids
WO1999036383A1 (fr) Substances capables de provoquer l'apoptose
US20070225252A1 (en) Ketogenic Saccharides
JP7202440B1 (ja) 組成物及びその製造方法並びに界面活性剤
JPH06113872A (ja) クロロフィル類組成物の新規製造法
JP2002540115A (ja) 酸化防止剤および／または乳化剤としての使用のための、疎水性基を用いて置換された１，５−アンヒドロ−ｄ−フルクトース
JPS58201736A (ja) ポリプレノ−ルの製造方法
EP0866137B1 (en) Process for producing calcium salt of (-)-Erythrohydroxycitric acid
FR2981274A1 (fr) Procede pour la preparation de complexes comprenant de l'amylose assemble avec au moins une molecule organique d'interet
WO2001055222A1 (fr) PROCEDE DE PREPARATION DE MONO-, DI- ET TRICARBOXY CYCLODEXTRINES PAR OXYDATION REGIOSELECTIVE EN POSITION 6 D'α ou β ou η CYCLODEXTRINES NATIVES
KR20020019509A (ko) 공역 리놀레인산 유도체 및 그의 합성방법
JPS60155143A (ja) 天然ロウからの脂肪族高級アルコ−ルの分離法
KR20090035175A (ko) 고순도 불포화 지방산의 제조방법
Iskineyeva et al. Preparation of encapsulated α-tocopherol acetate and study of its physico-chemical and biological properties
Oliveira et al. Synthesis and Application of Acetil-β-cyclodexitrin on Essential Oil

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees